Registry for kidney health during pregnancy
Kidney and Pregnancy Registry
Brugmann University Hospital · NCT06067867
This study is trying to understand how kidney diseases affect pregnancy and the health of mothers by collecting information from women before, during, and after their pregnancies.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 600 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Brugmann University Hospital (other) |
| Locations | 1 site (Brussels) |
| Trial ID | NCT06067867 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect data on women with kidney diseases and their experiences during pregnancy. It focuses on understanding how pre-existing kidney conditions affect pregnancy outcomes and maternal health. The study will extract data from medical files of women at different stages: pre-conception, during pregnancy, and postpartum. By analyzing this data, researchers hope to identify complications and improve care for pregnant women with kidney issues.
Who should consider this trial
Good fit: Ideal candidates include women of childbearing age with pre-existing kidney damage or related health issues, as well as pregnant women experiencing renal complications.
Not a fit: Patients without any kidney issues or those not planning to conceive may not receive benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better management of kidney-related complications during pregnancy, improving outcomes for both mothers and their babies.
How similar studies have performed: While there may be limited studies specifically focused on this registry approach, existing research has highlighted the importance of monitoring kidney health during pregnancy, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Pre-conception consultations Woman of childbearing age with: * Renal damage (glomerular, tubular disease, renal lithiasis, systemic disease, metabolic diseases, congenital diseases, etc.) * Hematological disorders (sickle cell disease) * Kidney transplantation * High blood pressure (hypertension) * Pre-kidney transplant assessment in progress for discussion of contraception and pregnancy after kidney transplantation * Preeclampsia * Multiple miscarriages * IUGR and low birth weight in the fetus * Family history of kidney disease 2. Peri-gravid consultations Pregnant women with * Pre-existing kidney damage * De novo renal failure (IR) * Proteinuria * Hematuria * Chronic hypertension * Pregnancy hypertension * Renal lithiasis 3. Postpartum consultations Postpartum women with * Early/late pre-eclampsia * Eclampsia / Hemolysis Elevated Liver enzymes Low Platelet (HELLP) syndrome * Pregnancy hypertension * Postpartum hemorrhage * De novo renal failure postpartum Exclusion Criteria: Male patients Menopausal patients
Where this trial is running
Brussels
- CHU Brugmann — Brussels, Belgium (RECRUITING)
Study contacts
- Principal investigator: Christelle Fosso — CHU Brugmann
- Study coordinator: Christelle Fosso
- Email: Christelle.FOSSO@chu-brugmann.be
- Phone: 3224772016
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Kidney Diseases